Transgenic mice studies of immediate-early genes: from markers to mutants

  • G. Kasof
  • T. Curran
  • J. I. Morgan

Abstract

Eurokaryotic cells can selectively modify gene transcription in response to alterations in the levels of extracellular signals. In general, genomic targets of extracellular stimuli can be devided into two categories based upon the characteristics of their regulation (reviewed in Curran and Morgan 1987; Morgan and Curran 1989). Thus, alterations in transcription of “primary response” genes is independent of protein synthesis and is typically initiated within minutes. In contrast, changes in the expression of “delayed”, or “late response” genes occur with a lag of several hours and requires ongoing protein synthesis. This nomenclature is based partly upon analogies with certain viruses that control their replicative cycle by the sequential activation of groups of genes (i.e. immediate-early, early and late genes). As their name suggests, viral immediate-early genes are transcriptionally active immediately upon infection of the host cell and are transcribed even in the absence of protein synthesis. Their products serve to coordinate further progression of the viral life cycle by regulating transcription of viral early genes (reviewed in Berk 1986). This has led, again by analogy, to the suggestion that the proteins encoded by the cellular primary response genes contribute to the transcriptional regulation of late response genes (Goelet et al. 1986; Morgan and Curran 1989). This would also imply that primary response gene products should encode inducible transcription factors or proteins capable of modifying the activity of existing transcription factors.

Keywords

Kainic Acid Cereb Blood Flow Serum Response Element Complex Partial Epilepsy Ongoing Protein Synthesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akhtar S, Juliano RL (1992) Cellular uptake and intracellular fate of antisense oligonucleotides. Trends Cell Biol 2:139–144PubMedCrossRefGoogle Scholar
  2. An G, Lin TN, Liu JS, Xue JJ, He YY, Hsu CY (1993) Expression of c-fos and c-jun family genes after focal cerebral ischemia. Ann Neurol 33/5:457–464CrossRefGoogle Scholar
  3. Angel P, Allegretto EA, Okino ST, Hattori K, Boyle WJ, Hunter T, Karin M (1988) Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature 332:166–171PubMedCrossRefGoogle Scholar
  4. Bading H, Ginty, DD, Greenberg ME (1993) Regulation of gene expression in hippocampal neurons by distinct calcium signalling pathways. Science 260:181–186PubMedCrossRefGoogle Scholar
  5. Ben-Ari Y, Temblay E, Riche D, Ghilini G, Naquet R (1981) Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neurosci 6:1361–1391CrossRefGoogle Scholar
  6. Berk AJ (1986) Adenovirus promoters and transactivation. Ann Rev Genet 20:45–79PubMedCrossRefGoogle Scholar
  7. Bohmann D, Bos TJ, Admon A, Nishimura T, Vogt PK, Tjian R (1987) Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238:1386–1392PubMedCrossRefGoogle Scholar
  8. Chiasson BJ, Hooper ML, Murphy PR, Robertson HA (1992) Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain. Europ J Pharm 227:451–453CrossRefGoogle Scholar
  9. Cohen D, Curran T (1988) fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen. Mol Cell Biol 8:2063–2069PubMedGoogle Scholar
  10. Colotta F, Polentarutti N, Sironi M, Mantovani A (1992) Expression and involvement of c-fos and c-jun proto-oncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 267/26:18278–18283Google Scholar
  11. Curran T, Morgan JI (1987) Memories of fos. Bio Essays 7/6:255–258Google Scholar
  12. Curran T, Teich NM (1982) Candidate product of the FBJ murine osteosarcoma virus oncogene: Characterization of a 55,000 dalton phosphoprotein. J Virology 42:114–122PubMedGoogle Scholar
  13. Dempsey RJ, Carney JM, Kindy MS (1991) Modulation of ornithine decarboxylase mRNA following transient ischemia in the gerbil brain. J Cereb Blood Flow Metab 11:979–985PubMedCrossRefGoogle Scholar
  14. Dragunow M, Robertson HA (1987) Kindling stimulation induces c-fos protein(s) in granule cells of the rat dentate gyrus. Nature 329:441–442PubMedCrossRefGoogle Scholar
  15. Dragunow M, Robertson HA (1988) Brain injury induces c-fos protein(s) in nerve and glial cells in adult mammalian brain. Brain Res 455:295–299PubMedCrossRefGoogle Scholar
  16. Draisci G, Iadarola MJ (1989) Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Mol Brain Res 6:31–37PubMedCrossRefGoogle Scholar
  17. Fagarasan MO, Aiello F, Muegge K, Durum S (1990) Interleukin 1 induces ß-endorphin secretion via Fos and Jun in AtT-20 pituitary cells. Proc Natl Acad Sci USA 87:7871–7874PubMedCrossRefGoogle Scholar
  18. Gentz R, Rauscher FJ III, Abate C, Curran T (1989) Parallel association of Fos and Jun leucine zippers juxtaposes DNA binding domains. Science 243:1695–1699PubMedCrossRefGoogle Scholar
  19. Goddard GV, McIntyre DC, Leech CK (1969) A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 25:295–330PubMedCrossRefGoogle Scholar
  20. Goelet P, Castellucci VF, Schacher S, Kandel ER (1986) The long and the short of a long-term memory — a molecular framework. Nature 322:419–422PubMedCrossRefGoogle Scholar
  21. Hai T, Curran T (1991) Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci USA 88:3720–3724PubMedCrossRefGoogle Scholar
  22. Hazel TG, Nathans D, Lau LF (1988) A gene inducible by serum growth factors encodes a member of the steroid and thryoid hormone receptor superfamily. Proc Natl Acad Sci USA 85:8444–8448PubMedCrossRefGoogle Scholar
  23. Hengerer B, Lindholm D, Heumann R, Ruther U, Wagner EF (1990) Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. Proc Natl Acad Sci USA 87:3899–3903PubMedCrossRefGoogle Scholar
  24. Hershman HR (1989) Extracellular signals, transcriptional responses and cellular specificity. Trends Biochem Sci 14:455–458CrossRefGoogle Scholar
  25. Hilberg F, Wagner EF (1992) Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicity. Oncogene 7:2371–2380PubMedGoogle Scholar
  26. Hilbush BS, Curran T, Morgan JI (1994) Cellular immediate-early genes in the nervous system:genes for all reasons? In: Fuxe K, Agnati LF, Leon A, Ottoson D (eds) Trophic Regulation of the Basal Ganglia. Focus on dopamine Neurons. Pergamon Press, 301–315Google Scholar
  27. Isackson PF, Huntsman MM, Murray KD, Gall CM (1991) BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF. Neuron 6:937–948PubMedCrossRefGoogle Scholar
  28. Jacewitz M, Kiessling M, Pulsinelli WA (1986) Selective gene expression of focal cerebral ischemia. J Cereb Blood Flow Metab 6:263–272CrossRefGoogle Scholar
  29. Johnson RS, Spiegelman BM, Papaioannou V (1992) Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71:577–586PubMedCrossRefGoogle Scholar
  30. Jorgenson M, Deckert J, Wright D, Gehlert D (1989) Delayed c-fos proto-oncogene expression in the rat hippocampus induced by transient global cerebral ischemia: an in situ hybridization study. Brain Res 484:393–398CrossRefGoogle Scholar
  31. Kanamatsu T, McGinty JF, Mitchell CL, Hong JS (1986) Dynorphin- and enkephalin-like immunoreactivity is altered in limbic-basal ganglia regions of rat brain after repeated electroconvulsant shock. J Neurosci 6/3:644–649Google Scholar
  32. Kindy M, Verma I (1988) Inhibition of c-fos gene expression does not alter the differentiation pattern of PC12 cells. In: Melton D (ed) Antisense DNA and RNA. Cold Spring Harbor Laboratory, pp 129–133Google Scholar
  33. Kobierski LA, Chu H-M, Tan Y, Comb MJ (1991) cAMP-dependent regulation of proenkephalin by Jun D and Jun B: Positive and negative effects and AP-1 proteins. Neurobiol 88:10222–10226Google Scholar
  34. Kononen J, Honkaniemi J, Alho H, Koistinaho J, Iadarola M, Pelto-Huikko M (1992) Fos-like immunoreactivity in the rat hypothalamic-pituitary axis after immobilization stress. Endocrin 130/5:3041–3047CrossRefGoogle Scholar
  35. Kononen J, Koistinaho J, Alho H (1990) Circadian rhythm in c-fos-like immunoreactivity in the rat brain. Neurosci Lett 120:150–108CrossRefGoogle Scholar
  36. Konradi, C, Kobierski LA, Nguyen TV, Heckers S, Hyman SE (1993) The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum. Proc Natl Acad Sci USA 90:7005–7009PubMedCrossRefGoogle Scholar
  37. Lamb NJC, Fernandez A, Toukine N, Jeanteur P, Blanchard J-M (1990) Demonstration lin living cells of an intragenic negatie regulatory element within the rodent c-fos gene. Cell 61:485–496PubMedCrossRefGoogle Scholar
  38. Landschulz WH, Johnson PF, McKnight SL (1988) The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240:1759–1764PubMedCrossRefGoogle Scholar
  39. Largent BL, Sosnowski RG, Reed RR (1993) Ionotropic glutamate receptor subtypes activate c-fos transcription by distinct calcium-requiring intracellular signalling pathways. Neuron 10:31–41CrossRefGoogle Scholar
  40. Lerea LS and McNamara JO (1993) Ionotropic glutamate subtypes activate c-fos trancription by distinct calcium-requiring intacellular signalling pathways. Neuron 10:31–41PubMedCrossRefGoogle Scholar
  41. Lloyd A, Yancheva N, Wasylyk B (1991) Transformation suppressor activity of a Jun transcription factor lacking its activation domain. Nature 352:635–638PubMedCrossRefGoogle Scholar
  42. Logeat F, Israel N, Ten R, Blank V, Le Bail O, Kourilsky P, Israel A (1991) Inhibition of transcription factors belonging to the rel/NF-KB family by a transdominant negative mutant. EMBO J 10/7:1827–1832Google Scholar
  43. Lucas JJ, Mellstrom B, Colado MI, Naranjo JR (1993) Molecular mechanisms of pain: Serotonin 1A receptor agonists trigger transactivation of c-fos of the prodynorphin gene in spinal cord neurons. Neuron 10:599–611PubMedCrossRefGoogle Scholar
  44. Maki Y, Bos TJ, Davis C, Starbuck M, Vogt PK (1987) Avian sarcoma virus 17 carries the jun oncogene. Proc Natl Acad Sci USA 84:2848–2852PubMedCrossRefGoogle Scholar
  45. Matsui M, Tokuhara M, Konuma Y, Nomura N, Ishizaki R (1990) Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation. Oncogene 5:249–255PubMedGoogle Scholar
  46. McNamara JO, Bonhaus DW, Crain BJ, Gellman RL, Shin C (1987) Biochemical and pharmacologic studies of neurotransmitters in the kindling model. In: Jobe PC, Laird HE (eds) Neurotransmitters and Epilepsy. Humana Press, Clifton NJ, pp 115–148CrossRefGoogle Scholar
  47. Milbrandt J (1987) A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 238:797–799PubMedCrossRefGoogle Scholar
  48. Miller AD, Curran T, Verma IM (1984) c-Fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell 36:51–60PubMedCrossRefGoogle Scholar
  49. Molinar-Rode R, Smeyne RJ, Curran T, Morgan JI (1993) Regulation of proto-oncogene expression in adult and developing lungs. Mol Cell Biol 13/6:3213–3220Google Scholar
  50. Morgan JI, Cohen DR, Hemstead JL, Curran T (1987) Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237:192–197PubMedCrossRefGoogle Scholar
  51. Morgan JI, Curran T (1989) Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. TINS 12/11:459–462Google Scholar
  52. Morgan JI, Curran T (1991a) Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci 14:421–451PubMedCrossRefGoogle Scholar
  53. Morgan JI, Curran T (1991b) Proto-oncogene transcription factors and epilepsy. TIPS 12/9:343–349Google Scholar
  54. Murre C, McCaw PS, Vaessin H, Caudy M, Jan LY, Jan YN, Cabrera CV, Buskin JN, Hauschka SD, Lassar AB, Weintraub H, Baltimore D (1989) Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58:537–544PubMedCrossRefGoogle Scholar
  55. Nakabeppu Y, Ryder K, Nathans D (1988) DNA binding activities of three murine Jun proteins: stimulation by Fos. Cell 55:907–910PubMedCrossRefGoogle Scholar
  56. Oberdick J, Smeyne RJ, Jann JR, Zackson S, Morgan JI (1990) A promoter that drives transgenic expression in cerebellar purkinje and retinal bipolar neurons. Science 248:223–226PubMedCrossRefGoogle Scholar
  57. Okuno H, Suzuki T, Yoshida T, Hashimoto Y, Curran T, Iba H (1991) Inhibition of jun transformation by a mutated fos gene: design of an antioncogene. Oncogene 6:1491–1497PubMedGoogle Scholar
  58. O’Shea EK, Rutkowski R, Kim PA (1992) Mechanism of specificity in the Fos-Jun oncoprotein heterodimer. Cell 68: 699–708PubMedCrossRefGoogle Scholar
  59. Patterson SL, Grover LM, Schwarzkroin PA, Bothwell M (1992) Neurotrophin expression in rat hippocampal slices: a stimulus paradigm inducing LTP in CA1 evokes increases in BDNF and NT-3 mRNAs. Neuron 9:1081–1088PubMedCrossRefGoogle Scholar
  60. Prywes R, Fisch TM, Roeder RG (1988) Transcriptional regulation of c-fos. Cold Spr Harb Symp Quant Bio 53:739–748Google Scholar
  61. Rauscher FJ III, Voulalas PJ, Franza BR Jr, Curran T (1988) Fos and Jun bind cooperatively to the AP-1 site: reconstruction in vitro. Genes Dev 2:1687–1699PubMedCrossRefGoogle Scholar
  62. Riabowol KT, Vosatka RJ, Ziff EB, Lamb NJ, Feramisco JR (1988) Microinjection of fos-specific antibodies blocks DNA synthesis in fibroblast cells. Mol and Cell Biol 8:1670–1676Google Scholar
  63. Robertson GS, Herrera DG, Dragunow M, Robertson HA (1989) L-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra. Eur J Pharm 159:99–100CrossRefGoogle Scholar
  64. Robertson GS, Robertson HA (1987) D1 and D2 dopamine agonist synergism: separate site of action? TIPS 8:295–299Google Scholar
  65. Ruther U, Garber C, Komitowski D, Muller R, Wagner EF (1987) Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature 325:412–418PubMedCrossRefGoogle Scholar
  66. Ryder K, Lau LF, Nathans D (1988) A gene activated by growth factors is related to the oncogene v-jun. Proc Natl Acad Sci USA 85:1487PubMedCrossRefGoogle Scholar
  67. Ryder K, Lanahan A, Perez-Albuerne E, Nathans D (1989) Jun D: A third member of the Jun gene family. Proc Natl Acad Sci 86:1500–1503PubMedCrossRefGoogle Scholar
  68. Saffen D, Cole A, Worley P, Christy B, Ryder K, Baraban J (1988) Convulsant-induced increase in transcription factor messenger RNAs in rat brain. Proc Natl Acad Sci USA 85:7795–7799PubMedCrossRefGoogle Scholar
  69. Sagar SM, Sharp FR, Curran T (1988). Expression of c-fos protein in brain: Metabolic mapping at the cellular level. Science 240:1328–1331PubMedCrossRefGoogle Scholar
  70. Sawai S, Shimono A, Hanaoka K, Kondoh H (1991) Embryonic lethality resulting from disruption of both N-myc alleles in mouse zygotes. New Biol 3/9:861–869Google Scholar
  71. Schilling K, Luk D, Morgan JI, Curran T (1991) Regulation of a fos-lacZ fusion gene: A paradigm for quantitative analysis of stimulus-transcription coupling. Proc Natl Acad Sci USA 88:5655–5669CrossRefGoogle Scholar
  72. Schuermann M, Neuberg M, Hunter JB, Jenuwein T, Ryseck, RP, Bravo R, Muller R (1989) The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation. Cell 56:507–516PubMedCrossRefGoogle Scholar
  73. Sheng M, McFadden G, Greenberg ME (1990) Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron 4:571–582PubMedCrossRefGoogle Scholar
  74. Shin C, McNamara JO, Morgan JI, Curran T, Cohen DR (1990) Induction of c-fos mRNA expression by afterdischarge in the hippocampus or naive and kindled rats. J Neurochem 55/3:1050–1055CrossRefGoogle Scholar
  75. Siesjo BK, Bengtsson F (1989) Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischema, Hypogylcemia, and spreading depression: a unifying hypothesis. J Cereb Blood Flow Metab 9:127–140PubMedCrossRefGoogle Scholar
  76. Smeyne RJ, Schilling K, Robertson L, Luk D, Oberdick J, Curran T, Morgan JI (1992a) Fos-lacZ transgenic mice: mapping sites of gene induction in the central nervous system. Neuron 8:13–23PubMedCrossRefGoogle Scholar
  77. Smeyne RJ, Curran T, Morgan JI (1992b) Temporal and spatial expression of a fos-lacZ transgene in the developing nervous system. Mol Brain Res 16:158–162PubMedCrossRefGoogle Scholar
  78. Smeyne RJ, Vendrell J, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T, Morgan JI (1993) Continuous c-fos expression precedes programmed cell death in vivo. Nature 363:166–169PubMedCrossRefGoogle Scholar
  79. Sonnenberg JL, Mitchelmore C, Macgregor-Leon PF, Hempstead J, Morgan JI, Curran T (1989a) Glutamate receptor agonists increase the expression of Fos, Fra and AP-1 DNA binding activity in the mammalian brain. J Neurosci Res 24:72–80PubMedCrossRefGoogle Scholar
  80. Sonnenberg JL, Rauscher FJ III, Morgan JI, Curran T (1989b) Regulation of proenkephalin by Fos and Jun. Science 246:1622–1625PubMedCrossRefGoogle Scholar
  81. Sonnenberg JL, Macgregor-Leon PF, Curran T, Morgan JI (1989c) Dynamic alterations occur in the levels and composition of transcription factor AP-1 complexes and seizure. Neuron 3:359–365PubMedCrossRefGoogle Scholar
  82. Stewart TA, Pattengale PK, Leder P (1984). Spontaneous mammary adenocarinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38:627–637PubMedCrossRefGoogle Scholar
  83. Sukhatame VP, Cao X, Chang LC, Tsai-Morris CH, Stamenkovich D, Ferreira PCP, Cohen DR, Edwards SA, Shows TB, Curran T, Le Beau MM, Adamson ED (1988) A zinc finger-encoding gene corregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53:37–43CrossRefGoogle Scholar
  84. Sutula T, Xiao-Xian H, Cavazos J, Scott G (1988) Synaptic reorganization in the hippocampus induced by abnormal functional activity. Science 239:1147–1150PubMedCrossRefGoogle Scholar
  85. Trugman JM, Wooten GF (1986) The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigra. Brain Res. 379:264–274PubMedCrossRefGoogle Scholar
  86. Turner R, Tijan R (1989) Leucine repeats and an adjacent DNA binding domain mediate the formation of functional cFos-cJun heterodimers. Science 243:1689–1691PubMedCrossRefGoogle Scholar
  87. Wang ZQ, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U, Wagner EF (1992) Bone and haematopioetic defects in mice lacking c-fos. Nature 360:741–435PubMedCrossRefGoogle Scholar
  88. Welsh FA, Moyer DJ, Harris VA (1992) Regional expression of heat shock protein 70 mRNA and c-fos mRNA following focal ischemia in rat brain. J Cereb Blood Flow Metab 12:204–212PubMedCrossRefGoogle Scholar
  89. White JD, Gall CM (1987) Differential regulation of neuropeptide and proto-oncogene mRNA content in the hippocampus following recurrent seizures. Mol Brain Res 3:21–29CrossRefGoogle Scholar
  90. Zerial M, Toschi L, Ryseck RP, Schuermann M, Muller R, Bravo R (1989) The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO J 8:805–813PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • G. Kasof
    • 1
    • 2
  • T. Curran
    • 1
  • J. I. Morgan
    • 1
  1. 1.Roche Institute of Molecular BiologyRoche Research Center NutleyUSA
  2. 2.Dept. of Biological SciencesColumbia UniversityNew YorkUSA

Personalised recommendations